Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 Inhibitors

por O’Sullivan, Ciara C
Publicado 2015

Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer

por O’Sullivan, Ciara C., Bates, Susan E.
Publicado 2016

The emerging role of CDK4/6i in HER2-positive breast cancer

por O’Sullivan, Ciara C., Suman, Vera J., Goetz, Matthew P.
Publicado 2019

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors

por O’Sullivan, Ciara C., Moon, Dominic H., Kohn, Elise C., Lee, Jung-Min
Publicado 2014

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care

por Garreffa, Emanuele, Hamad, Ahmed, O'Sullivan, Ciara C., Hazim, Antonious Z., York, Joanne, Puri, Shama, Turnbull, Anne, Robertson, John F., Goetz, Matthew P.
Publicado 2021

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial

por Haddad, Tufia C., Suman, Vera J., D’Assoro, Antonino B., Carter, Jodi M., Giridhar, Karthik V., McMenomy, Brendan P., Santo, Katelyn, Mayer, Erica L., Karuturi, Meghan S., Morikawa, Aki, Marcom, P. Kelly, Isaacs, Claudine J., Oh, Sun Young, Clark, Amy S., Mayer, Ingrid A., Keyomarsi, Khandan, Hobday, Timothy J., Peethambaram, Prema P., O’Sullivan, Ciara C., Leon-Ferre, Roberto A., Liu, Minetta C., Ingle, James N., Goetz, Matthew P.
Publicado 2023

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

por Litton, Jennifer K., Regan, Meredith M., Pusztai, Lajos, Rugo, Hope S., Tolaney, Sara M., Garrett-Mayer, Elizabeth, Amiri-Kordestani, Laleh, Basho, Reva K., Best, Ana F., Boileau, Jean-Francois, Denkert, Carsten, Foster, Jared C., Harbeck, Nadia, Jacene, Heather A., King, Tari A., Mason, Ginny, O'Sullivan, Ciara C., Prowell, Tatiana M., Richardson, Andrea L., Sepulveda, Karla A., Smith, Mary Lou, Tjoe, Judy A., Turashvili, Gulisa, Woodward, Wendy A., Butler, Lynn Pearson, Schwartz, Elena I., Korde, Larissa A.
Publicado 2023

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

por Freedman, Rachel A., Gelman, Rebecca S., Anders, Carey K., Melisko, Michelle E., Parsons, Heather A., Cropp, Anne M., Silvestri, Kelly, Cotter, Christine M., Componeschi, Kathryn P., Marte, Juan M., Connolly, Roisin M., Moy, Beverly, Van Poznak, Catherine H., Blackwell, Kimberly L., Puhalla, Shannon L., Jankowitz, Rachel C., Smith, Karen L., Ibrahim, Nuhad, Moynihan, Timothy J., O’Sullivan, Ciara C., Nangia, Julie, Niravath, Polly, Tung, Nadine, Pohlmann, Paula R., Burns, Robyn, Rimawi, Mothaffar F., Krop, Ian E., Wolff, Antonio C., Winer, Eric P., Lin, Nancy U.
Publicado 2019